Schonfeld Strategic Advisors LLC

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1665241 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,042,135

+$2,357,271 QoQ

Shares Held

89,765

+168.3% QoQ

Ownership

0.075%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#84

of 197 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. NAMS ranks #41 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,042,135	89,765	+168.3%	Shares	Sole	2026-08-14
2025-03-31	$684,864	33,457	+64.1%	Shares	Sole	2025-05-15
2024-12-31	$523,817	20,382	-58.8%	Shares	Sole	2025-02-14
2024-06-30	$949,607	49,433	-59.5%	Shares	Sole	2024-08-14
2024-03-31	$2,885,300	122,000	+82.4%	Shares	Sole	2024-05-15
2023-12-31	$747,273	66,900	+3.4%	Shares	Sole	2024-02-14
2023-09-30	$598,475	64,700	+12.9%	Shares	Sole	2023-11-14
2023-06-30	$681,297	57,300	+90.4%	Shares	Sole	2023-08-14
2023-03-31	$399,126	30,100	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.